Eucrates Biomedical Acquisition Corp. Quarterly Net Cash Provided by (Used in) Financing Activities in USD from Q3 2020 to Q1 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Eucrates Biomedical Acquisition Corp. annual/quarterly Net Cash Provided by (Used in) Financing Activities history and growth rate from Q3 2020 to Q1 2022.
  • Eucrates Biomedical Acquisition Corp. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2022 was $250K.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Period Value YoY Chg Change % Date Report Filed
Q1 2022 $250K Mar 31, 2022 10-Q 2022-05-23
Q4 2020 $106M Dec 31, 2020 10-K 2022-04-11
Q3 2020 -$85.2K Sep 30, 2020 10-Q 2021-11-22
* An asterisk sign (*) next to the value indicates that the value is likely invalid.